05/06/2024
4:17 PM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2024
9:35 AM | ESSA Pharma (Issuer)
Glickman Richard M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
5:16 PM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
2:02 PM | ESSA Pharma (Subject)
Virsik Peter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/28/2024
11:34 AM | ESSA Pharma (Issuer)
Kantoff Philip W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:35 AM | ESSA Pharma (Issuer)
Martin John Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:36 AM | ESSA Pharma (Issuer)
Merendino Lauren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/28/2024
11:38 AM | ESSA Pharma (Issuer)
Requadt Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:39 AM | ESSA Pharma (Issuer)
Sollis Gary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:40 AM | ESSA Pharma (Issuer)
Thorell Marella (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:41 AM | ESSA Pharma (Issuer)
ZWEIFACH SANFORD S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:25 AM | Cesano Alessandra (Reporting)
ESSA Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:27 AM | ESSA Pharma (Issuer)
Parkinson David Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:30 AM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:31 AM | ESSA Pharma (Issuer)
Wood David S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:32 AM | BERGER FRANKLIN M (Reporting)
ESSA Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:33 AM | ESSA Pharma (Issuer)
Glickman Richard M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
4:18 PM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
5:50 PM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:05 AM | ESSA Pharma (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G | |
02/13/2024
6:01 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
6:01 AM | ESSA Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/13/2024
5:04 AM | BB BIOTECH AG (Filed by)
ESSA Pharma (Subject)
| Form SC 13G/A | |
02/08/2024
10:29 AM | ESSA Pharma (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G | |
02/07/2024
10:29 AM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
7:27 AM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
8:15 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2024
3:09 PM | ESSA Pharma (Subject)
Soleus Capital, LLC (Filed by)
| Form SC 13G/A | |
01/17/2024
7:57 PM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
12:41 PM | ESSA Pharma (Issuer)
Requadt Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2024
2:50 PM | ESSA Pharma (Subject)
Gagnon Robert E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
7:06 PM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
8:57 PM | ESSA Pharma (Issuer)
Parkinson David Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
6:00 AM | ESSA Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
12/12/2023
6:01 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/24/2023
10:11 AM | ESSA Pharma (Issuer)
Wood David S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
5:22 PM | BERGER FRANKLIN M (Reporting)
ESSA Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
4:45 PM | BERGER FRANKLIN M (Reporting)
ESSA Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
8:44 PM | ESSA Pharma (Filer)
| Form 424B5 | |
10/26/2023
7:07 PM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2023
3:19 PM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad) If you think AI is big, then you have got to check out something I call Imperium…
By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details |
10/10/2023
11:15 PM | ESSA Pharma (Filer)
| Form EFFECT | |
10/03/2023
3:35 PM | ESSA Pharma (Filer)
| Form S-3/A | |
09/19/2023
3:43 PM | ESSA Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/18/2023
6:05 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/15/2023
6:56 PM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
6:15 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
6:01 AM | ESSA Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/06/2023
3:30 PM | ESSA Pharma (Issuer)
Merendino Lauren (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
